Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 6—June 2025

CME ACTIVITY - Synopsis

Clinical Manifestations, Risk Factors, and Disease Burden of Rickettsiosis, Cambodia, 2007–2020

Gerard C. Kelly, Agus Rachmat, Long Khanh Tran, Chonthida Supaprom, Hip Phireak, Satharath Prom, Heng Sopheab, Nora Cleary, Michael von Fricken, Christina M. Farris, and Andrew G. LetiziaComments to Author 
Author affiliation: Culmen International, LLC, Alexandria, Virginia, USA (G.C. Kelly, L.K. Tran); AC Investment Co, contractor for NAMRU INDO PACIFIC, Phnom Penh, Cambodia (A. Rachmat, C. Supaprom, H. Phireak); Oxford University Clinical Research Unit, Jakarta, Indonesia (A. Rachmat); Cambodia Ministry of National Defense Department of Health, Phnom Penh (S. Prom); Cambodia National Institute of Public Health, Phnom Penh (H. Sopheab); University of Florida College of Public Health and Health Professions, Gainesville, Florida, USA (N. Cleary, M. von Fricken); US Naval Medical Research Command Viral and Rickettsial Diseases Department, Silver Spring, Maryland, USA (C.M Farris); US Naval Medical Research Unit INDO PACIFIC, Singapore (A.G. Letizia)

Main Article

Figure 2

Flowchart of patients enrolled in rickettsioses cross-sectional prevalence study of clinical manifestations, risk factors, and disease burden of rickettsiosis, Cambodia, 2007–2020. Columns indicate percentage of total AUFI patents (blue), percentage of participants tested for rickettsioses (yellow), and percentage of infected persons detected per year (red). No testing was conducted in 2009. AUFI, acute undifferentiated febrile illness.

Figure 2. Flowchart of patients enrolled in rickettsioses cross-sectional prevalence study of clinical manifestations, risk factors, and disease burden of rickettsiosis, Cambodia, 2007–2020. Columns indicate percentage of total AUFI patents (blue), percentage of participants tested for rickettsioses (yellow), and percentage of infected persons detected per year (red). No testing was conducted in 2009. AUFI, acute undifferentiated febrile illness.

Main Article

Page created: March 18, 2025
Page updated: May 27, 2025
Page reviewed: May 27, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external